Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice

Jenae Limoges, Yuri Persidsky, Paul Bock, Howard Eliot Gendelman

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV) dementia is a late complication of viral infection. Cognitive dysfunction revolves around the secretion of neurotoxins from immunologically competent virus-infected brain macrophages and microglia. Such macrophage neurotoxins are inflammatory factors that produce selective neuronal dysfunction and ultimately cell death. To evaluate the potential efficacy of antiinflammatory therapy for HIV dementia, dexamethasone was administered to severe combined immunodeficient mice with HIV-1 encephalitis. Mice were given therapeutic doses of dexamethasone before intracerebral inoculation with HIV-1-infected human monocytes. Histochemical evaluation showed a worsening of neuropathology after treatment, with astrogliosis and increased apoptosis of neurons. Laboratory investigation of the mechanisms for the dexamethasone effects revealed increased viability of HIV-infected macrophages and incomplete suppression of neurotoxic inflammatory secretions. The results suggest the need for caution in administering glucocorticoids for treatment of HIV encephalitis in humans.

Original languageEnglish (US)
Pages (from-to)1368-1381
Number of pages14
JournalJournal of Infectious Diseases
Volume175
Issue number6
DOIs
StatePublished - Jan 1 1997

Fingerprint

SCID Mice
Encephalitis
Dexamethasone
HIV-1
HIV
Macrophages
Neurotoxins
Dementia
Microglia
Virus Diseases
Therapeutics
Glucocorticoids
Monocytes
Cell Death
Anti-Inflammatory Agents
Apoptosis
Viruses
Neurons
Neuropathology
Brain

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice. / Limoges, Jenae; Persidsky, Yuri; Bock, Paul; Gendelman, Howard Eliot.

In: Journal of Infectious Diseases, Vol. 175, No. 6, 01.01.1997, p. 1368-1381.

Research output: Contribution to journalArticle

@article{c010fe55cf464c8985e063b4df32f5bd,
title = "Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice",
abstract = "Human immunodeficiency virus (HIV) dementia is a late complication of viral infection. Cognitive dysfunction revolves around the secretion of neurotoxins from immunologically competent virus-infected brain macrophages and microglia. Such macrophage neurotoxins are inflammatory factors that produce selective neuronal dysfunction and ultimately cell death. To evaluate the potential efficacy of antiinflammatory therapy for HIV dementia, dexamethasone was administered to severe combined immunodeficient mice with HIV-1 encephalitis. Mice were given therapeutic doses of dexamethasone before intracerebral inoculation with HIV-1-infected human monocytes. Histochemical evaluation showed a worsening of neuropathology after treatment, with astrogliosis and increased apoptosis of neurons. Laboratory investigation of the mechanisms for the dexamethasone effects revealed increased viability of HIV-infected macrophages and incomplete suppression of neurotoxic inflammatory secretions. The results suggest the need for caution in administering glucocorticoids for treatment of HIV encephalitis in humans.",
author = "Jenae Limoges and Yuri Persidsky and Paul Bock and Gendelman, {Howard Eliot}",
year = "1997",
month = "1",
day = "1",
doi = "10.1086/516469",
language = "English (US)",
volume = "175",
pages = "1368--1381",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice

AU - Limoges, Jenae

AU - Persidsky, Yuri

AU - Bock, Paul

AU - Gendelman, Howard Eliot

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Human immunodeficiency virus (HIV) dementia is a late complication of viral infection. Cognitive dysfunction revolves around the secretion of neurotoxins from immunologically competent virus-infected brain macrophages and microglia. Such macrophage neurotoxins are inflammatory factors that produce selective neuronal dysfunction and ultimately cell death. To evaluate the potential efficacy of antiinflammatory therapy for HIV dementia, dexamethasone was administered to severe combined immunodeficient mice with HIV-1 encephalitis. Mice were given therapeutic doses of dexamethasone before intracerebral inoculation with HIV-1-infected human monocytes. Histochemical evaluation showed a worsening of neuropathology after treatment, with astrogliosis and increased apoptosis of neurons. Laboratory investigation of the mechanisms for the dexamethasone effects revealed increased viability of HIV-infected macrophages and incomplete suppression of neurotoxic inflammatory secretions. The results suggest the need for caution in administering glucocorticoids for treatment of HIV encephalitis in humans.

AB - Human immunodeficiency virus (HIV) dementia is a late complication of viral infection. Cognitive dysfunction revolves around the secretion of neurotoxins from immunologically competent virus-infected brain macrophages and microglia. Such macrophage neurotoxins are inflammatory factors that produce selective neuronal dysfunction and ultimately cell death. To evaluate the potential efficacy of antiinflammatory therapy for HIV dementia, dexamethasone was administered to severe combined immunodeficient mice with HIV-1 encephalitis. Mice were given therapeutic doses of dexamethasone before intracerebral inoculation with HIV-1-infected human monocytes. Histochemical evaluation showed a worsening of neuropathology after treatment, with astrogliosis and increased apoptosis of neurons. Laboratory investigation of the mechanisms for the dexamethasone effects revealed increased viability of HIV-infected macrophages and incomplete suppression of neurotoxic inflammatory secretions. The results suggest the need for caution in administering glucocorticoids for treatment of HIV encephalitis in humans.

UR - http://www.scopus.com/inward/record.url?scp=0030922605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030922605&partnerID=8YFLogxK

U2 - 10.1086/516469

DO - 10.1086/516469

M3 - Article

C2 - 9180176

AN - SCOPUS:0030922605

VL - 175

SP - 1368

EP - 1381

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -